Indian billionaire, doctors spar over $900 brain blood-flow tracker Temple
Indian entrepreneur Deepinder Goyal is facing criticism from medical professionals over his new $900 wearable device, 'Temple'. Doctors argue that the device's health-tracking claims lack peer-reviewed evidence and should be regulated.
Why it matters
The controversy highlights the tension between tech-driven health innovation and the need for rigorous medical validation in consumer wearables.
A tiny, $900 wearable device being developed by an Indian billionaire entrepreneur and showcased by some of the country’s top sportspersons has sparked criticism from doctors who say its claims of tracking blood flow to the brain are exaggerated. The Temple device is less than 1 inch (2.54 cm) wide and weighs under 2 grams (0.07 oz). It sticks to the side of the head between the forehead and the ear, or the temple area. Promotional materials for the device, developed by Deepinder Goyal, say that its BrainFlow feature shows how well the brain is being supplied with blood in real time and its Entropy feature can detect how hard the body works to shed heat. Does the Temple wearable reveal useful information about brain health?
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in